# Comparing Quality of Recovery Between ESPB and IV Lidocaine After Major Breast Cancer Surgery

> **NCT06490718** · NA · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 80 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** USG ESPB
- **DRUG:** Intravenous Infusion

## Key facts

- **NCT ID:** NCT06490718
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-25
- **Primary completion:** 2025-07-17
- **Final completion:** 2025-07-20
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06490718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06490718, "Comparing Quality of Recovery Between ESPB and IV Lidocaine After Major Breast Cancer Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06490718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*